Patents for C12R 1 - Micro-organisms (92,025)
03/2000
03/09/2000WO2000012689A1 Polypeptides and polynucleotides from coagulase-negative staphylococci
03/09/2000WO2000012688A1 Ehrlichia canis 120-kda immunodominant antigenic protein and gene
03/09/2000WO2000012684A2 Temperature-sensitive and cold-adapted human parainfluenza virus type 2 (hpiv-2) and vaccines based on such virus
03/09/2000WO2000012561A1 Antihuman thymidylate synthase monoclonal antibodies and hybridomas producing the same
03/09/2000WO2000012559A1 Monoclonal antibodies against s100
03/09/2000WO2000012551A1 HUMAN LATENT TRANSFORMING GROWTH FACTOR-β BINDING PROTEIN 3
03/09/2000WO2000012546A1 MAMMALIAN elk POTASSIUM CHANNEL GENES
03/09/2000WO2000012535A2 Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof
03/09/2000WO2000012140A1 Method for labeling biopolymers using isotopes
03/09/2000WO2000012133A1 Neisseria spp. polypeptide, nucleic acid sequence and uses thereof
03/09/2000WO2000012129A2 Salmonella typhi vaccine compositions
03/09/2000WO2000012113A2 Method of modulating memory effector t-cells using a cd2-binding agent, and compositions
03/09/2000WO1999058686A3 Method for the production of 1,3-propanediol by recombinant organisms comprising genes for vitamin b12 transport
03/09/2000WO1999050397A3 Immobilized nuclease from serratia marcescens
03/09/2000DE4090565C2 Rekombinantes Herpesvirus-Pockenvirus-Vakzin A recombinant herpesvirus poxvirus vaccine
03/09/2000DE19839567A1 Organismen zur extrazellulären Herstellung von Riboflavin Organisms for the extracellular production of riboflavin
03/09/2000CA2633074A1 Elongase genes and uses thereof
03/09/2000CA2344591A1 Methods for improving the function of heterologous g protein-coupled receptors
03/09/2000CA2343046A1 Enhanced functional expression of g protein-coupled receptors
03/09/2000CA2342534A1 Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof
03/09/2000CA2341766A1 Mammalian elk potassium channel genes
03/09/2000CA2341715A1 Organisms for the extracellular production of riboflavin
03/09/2000CA2341703A1 Salmonella typhi vaccine compositions
03/09/2000CA2341627A1 Method for assessing the relative purity of viral gene transfer vector stocks
03/09/2000CA2341554A1 Process for the preparation of (2r)-piperidine derivatives
03/09/2000CA2341324A1 Transgene assay using stable agrobacterium rhizogenes transformation
03/09/2000CA2341308A1 Human latent transforming growth factor-.beta. binding protein 3
03/09/2000CA2341061A1 Targeted adenovirus vectors for delivery of heterologous genes
03/09/2000CA2340937A1 A new method of identifying non-host plant disease resistance genes
03/09/2000CA2340462A1 Ehrlichia canis 120-kda immunodominant antigenic protein and gene
03/09/2000CA2340276A1 Adenoviruses deleted in the iva2, 100k and/or preterminal protein sequences
03/09/2000CA2337869A1 Method for labeling biopolymers using isotopes
03/09/2000CA2336961A1 Temperature-sensitive and cold-adapted human parainfluenza virus type 2 (hpiv-2) and vaccines based on such virus
03/09/2000CA2281035A1 Dsba/dsbb/dsbc/dsbd expression plasmid
03/08/2000EP0984062A1 Production of human erythropoietin
03/08/2000EP0984061A1 Sialidases localized on plasma membranes and dna encoding the same
03/08/2000EP0984023A1 Cell surface molecule mediating cell adhesion and signal transmission
03/08/2000EP0983364A1 Dna polymerases having improved labeled nucleotide incorporation properties
03/08/2000EP0983361A1 Bacterial pheromones and uses therefor
03/08/2000EP0983354A2 Neurotrophic factor receptors
03/08/2000EP0983343A1 E. coli, salmonella or hafnia autoinducers
03/08/2000EP0983342A1 Culture medium with yeast or soy bean extract as aminoacid source and no protein complexes of animal origin
03/08/2000EP0983297A1 New echinocandine derivatives with antimicrobial activity
03/08/2000EP0804596A4 FUSION PROTEINS WITH CYTOTOXIC ACTIVITY AGAINST CELLS OVEREXPRESSING erbB3 AND/OR erbB4
03/08/2000EP0722501B1 Cloned pullulanase
03/08/2000EP0672136B1 Polypeptides, derived from endonexin 2, having hepatitis b virus receptor activity and their use in diagnostic and pharmaceutical compositions
03/08/2000EP0669970B1 Degradation of nucleic acids by peroxides
03/08/2000EP0619843B1 Icams immunoglobulin constant region soluble fusion proteins
03/08/2000CN1246893A Bacillus thuringiensis CryET29 compositions toxic to coleopteran insects and ctenocephalides spp
03/08/2000CN1050153C Process for production of biotin, mini-bacillus genus microbe and its application
03/07/2000US6034222 Method for the separation of recombinant pro-factor IX from recombinant factor IX
03/07/2000US6034124 Bactericides
03/07/2000US6034107 5-Substituted picolinic acid compounds and their production process
03/07/2000US6034061 Forming chondrocyte tissue in animal; administering bone morphogenic protein
03/07/2000US6034060 Peptide having an ability to promote the activation of protein C by thrombin
03/07/2000US6033903 Method of expressing and secreting soluble extracellular domains of human gonadotropin hormone receptors
03/07/2000US6033900 The use of a rhamnogalacturonase for degradation or modification of plant cell materials for increasing digestablility of animal feeds.
03/07/2000US6033890 Homogeneous immunoassays using mutant glucose-6-phosphate dehydrogenases
03/07/2000US6033883 Production of polyketides in bacteria and yeast
03/07/2000US6033882 Chiral synthesis of 2-hydroxy carboxylic acids with a dehydrogenase
03/07/2000US6033879 Process for the preparation of substituted aryl lactic acid containing cyclodepsipeptides with 24 ring atoms
03/07/2000US6033874 CRY1C polypeptides having improved toxicity to lepidopteran insects
03/07/2000US6033865 Human n-methyl-d-aspartate receptor type 1 subunits, DNA encoding same and uses therefor
03/07/2000US6033863 Monoclonal antibodies for selective immunological determination of high molecular weight, intact laminin forms in body fluids
03/07/2000US6033856 Promoter of the cdc25B gene, its preparation and use
03/07/2000US6033823 Mutated penicillin G acylase genes
03/07/2000CA1340919C Mouse monoclonal antibodies to hiv-1p24 and their use in diagnostic tests
03/02/2000WO2000011202A1 Cationic complexes of polymer-modified adenovirus
03/02/2000WO2000011201A1 Targeted alphavirus and alphaviral vectors
03/02/2000WO2000011196A1 Polynucleotide sequences
03/02/2000WO2000011188A1 Transgenic microbial polyhydroxyalkanoate producers
03/02/2000WO2000011175A1 Genetic method for the expression of polyproteins in plants
03/02/2000WO2000011169A2 Human cell signaling proteins (csig)
03/02/2000WO2000011167A2 Nucleic acids encoding a functional human purinoreceptor p2x2 and methods of producing and use thereof
03/02/2000WO2000011163A1 Dcr5, a bmp-binding protein, and applications thereof
03/02/2000WO2000011154A1 USE OF SUPPRESSOR tRNA'S TO REGULATE CYTOTOXICITY DURING THE PRODUCTION OF RECOMBINANT GENE PRODUCTS
03/02/2000WO2000011152A1 Streptavidin mutants having secondary functional domains
03/02/2000WO2000011144A2 Plastid-targeting nucleic acid sequence, beta-amylase sequence, a stimulus-responsive promoter and uses thereof
03/02/2000WO2000011139A1 Cell population containing non-fetal hemangioblasts and method for producing same
03/02/2000WO2000011037A1 Monoclonal antibodies specific for streptococcus mutans, and uses thereof
03/02/2000WO2000011036A1 AN ANTI-CYANOVIRIN ANTIBODY WITH AN INTERNAL IMAGE OF gp120, A METHOD OF USE THEREOF, AND A METHOD OF USING A CYANOVIRIN TO INDUCE AN IMMUNE RESPONSE TO gp120
03/02/2000WO2000010989A1 Process for the preparation of c-4 deacetyltaxanes
03/02/2000WO2000010593A1 USE OF mCRP TO SLOW CELL GROWTH AND TO PROMOTE MATURATION OF CELLS
03/02/2000WO2000010584A1 Method for detection of legionella bacteria employing purified antigen-specific antibodies
03/02/2000WO2000010582A2 Probiotic, lactic acid-producing bacteria and uses thereof
03/02/2000WO2000010380A1 Manipulation of tocopherol levels in transgenic plants
03/02/2000WO1999064619A3 Novel mannanases
03/02/2000WO1999063090A3 Protease inhibitor peptides
03/02/2000WO1999061604A3 A vector for gene trap, and a method for gene trapping by using the vector
03/02/2000WO1999057261A3 Human bmp-2 promoter and method for exploring bone-related substance by using the same
03/02/2000DE19839491A1 Verfahren zur Markierung von Biopolymeren mit Isotopen Methods for labeling of biopolymers with isotopes
03/02/2000CA2341516A1 Cationic complexes of polymer-modified adenovirus
03/02/2000CA2340857A1 Manipulation of tocopherol levels in transgenic plants
03/02/2000CA2340787A1 An anti-cyanovirin antibody with an internal image of gp120, a method of use thereof, and a method of using a cyanovirin to induce an immune response to gp120
03/02/2000CA2340595A1 Streptavidin mutants having secondary functional domains
03/02/2000CA2340471A1 Process for the preparation of c-4 deacetyltaxanes
03/02/2000CA2340335A1 Use of suppressor trna's to regulate cytotoxicity during the production of recombinant gene products
03/02/2000CA2339968A1 Dcr5, a bmp-binding protein, and applications thereof
03/02/2000CA2339871A1 Nucleic acids encoding a functional human purinoreceptor p2x2 and methods of producing and use thereof
03/02/2000CA2339860A1 Human cell signaling proteins (csig)